Trials / Recruiting
RecruitingNCT05170971
Fecal Microbiota Transplantation for Liver Failure
The Clinical Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Acute-on-chronic Liver Failure
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Ningbo Medical Center Lihuili Hospital · Other Government
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
To investigate the safety, adverse reactions and therapeutic effects of fecal microbiota transplantation on patients with liver failure;to investigate the effect of fecal microbiota transplantation on the intestinal microecology and "gut-liver axis immune system" of liver failure, and further optimization of fecal microbiota transplantation technology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | fecal microbiota transplantation | The fecal bacteria were transplanted once every 5 days for a total of 4 times |
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2024-12-31
- Completion
- 2026-12-31
- First posted
- 2021-12-28
- Last updated
- 2024-03-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05170971. Inclusion in this directory is not an endorsement.